Pursuant to Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we hereby wish to inform that company has acquired a running unit from M/s. MBP Pharmaceuticals Private Limited having its Corporate Office at SCO: No. 8, 2nd Floor, Phase-5, SAS Nagar, Mohali (Punjab) and has been renamed it as ANG LIFESCEINCES INDIA LIMITED- UNIT IV. The unit is situated at Khasra no. 145/ 139, Village Johdapur, Hadbast No. 192, Pragana Doon, Tehsil Baddi, District Solan (HP) and is constructed over land measuring 3 Bigha 13 Biswa. The unit is engaged in manufacturing of Pharmaceutical Products.
ANG Lifesciences India Ltd - 540694 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Preeti GoelDesignation :- Company Secretary and Compliance Officer
Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith voting results of 14th Annual General Meeting of ANG Lifesciences India Limited held on 30th Day of December, 2020.
Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations & Disclosures Requirements) Regulations 2015, please find enclosed herewith the Proceedings of the 14th Annual General Meeting of the Members of the ANG Lifesciences India Limited held on Wednesday, 30th day of December, 2020 at 10.30 A.M at the Registered Office of the Company at SCO 113, Darbara Complex, Ranjit Avenue Amritsar- 143001.